The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis
NCT ID: NCT05043935
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2021-11-22
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Aggressive Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy
NCT02049008
Photodynamic Therapy Associated With Full-mouth Ultrasonic Debridement in the Treatment of Severe Chronic Periodontitis
NCT01535690
Adjunctive Photodynamic Therapy in Treatment of Chronic Periodontitis
NCT01034501
Efficacy of Injectable Platelet-rich Fibrin Versus Platelet-Rich Plasma As Adjunctive to Scaling and Root Planning in Non-surgical Periodontal Therapy of Periodontitis Patients
NCT06685393
Adjunct Photodynamic Therapy in Chronic Periodontitis Among Cigarette-smokers.
NCT03308019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-PRF with antimicrobial photodynamic therapy
Application of L-PRF with antimicrobial photodynamic therapy in the defect
L-PRF with antimicrobial photodynamic therapy
Application of L-PRF with antimicrobial photodynamic therapy in the defect
antimicrobial photodynamic therapy
Application antimicrobial photodynamic therapy in the defect
antimicrobial photodynamic therapy without L-PRF
application of antimicrobial photodynamic therapy without L-PRF in the defect
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-PRF with antimicrobial photodynamic therapy
Application of L-PRF with antimicrobial photodynamic therapy in the defect
antimicrobial photodynamic therapy without L-PRF
application of antimicrobial photodynamic therapy without L-PRF in the defect
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non- smoker,
* not received any periodontal treatment within the last 6 months,
* no antibiotics, anti- inflammatory drugs or any other medication taken within the last 6 months
Exclusion Criteria
* any medical condition that required antibiotic prophylaxis before the treatment,
* smoking,
* pregnancy and lactation,
* ingestion of antibiotics, anti-inflammatory drugs or any other medication during the study period,
* any physical limitations or restrictions that might preclude normal oral hygiene procedures.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Rasheed Issa
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dalia R Issa, PhD
Role: PRINCIPAL_INVESTIGATOR
Kafrelsheikh University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, Kafrelsheikh University
Kafr ash Shaykh, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
waiting
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.